Should Platelet-rich Plasma (PRP) Be Offered as a Reasonable Strategy to Reduce Need for Surgery and Improve Functional Outcomes Measured by PROMIS in Patients Who Have Failed Physical Therapy?

Non-presenting author(s)

Steven M. Hadley, Jr., BA

Medical Student
Feinberg School of Medicine, Northwestern University

RB

Rachel Bergman, MD

Resident Physician
Northwestern University Feinberg School of Medicine
John J. Peabody, MD

Resident Physician
Northwestern University Feinberg School of Medicine

Nathan Repasky, BS

Medical Student
Northwestern University Feinberg School of Medicine

SW

Sarah J. Westvold, MPH

Statistician
Yale School of Medicine
Ryan Filler, MD

Foot and Ankle Fellow
Department of Orthopaedics, Northwestern University Feinberg School of Medicine
Milap Patel, DO

Clinical Assistant Professor, Orthopaedic Surgery
Department of Orthopaedics, Northwestern University Feinberg School of Medicine
Anish R. Kadakia, MD (he/him/his)

Professor, Orthopaedic Surgery
Department of Orthopaedics, Northwestern University Feinberg School of Medicine

Upon completion, participant will be able to understand the role of PRP in foot and ankle pathologies more effectively
Upon completion, participant will be able to explain how PRP impacts patient functional outcomes following PRP as measured by PROMIS.
Upon completion, participant will be able to discuss PRP as a potential treatment option for patients suffering from foot and ankle pathologies